Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116


The SSX family of cancer-testis antigens as target proteins for tumor therapy.

Smith HA, McNeel DG.

Clin Dev Immunol. 2010;2010:150591. doi: 10.1155/2010/150591. Epub 2010 Oct 11. Review.


Expression and immunotherapeutic targeting of the SSX family of cancer-testis antigens in prostate cancer.

Smith HA, Cronk RJ, Lang JM, McNeel DG.

Cancer Res. 2011 Nov 1;71(21):6785-95. doi: 10.1158/0008-5472.CAN-11-2127. Epub 2011 Aug 31.


Cancer/Testis Antigens: Expression, Regulation, Tumor Invasion, and Use in Immunotherapy of Cancers.

Salmaninejad A, Zamani MR, Pourvahedi M, Golchehre Z, Hosseini Bereshneh A, Rezaei N.

Immunol Invest. 2016 Oct;45(7):619-40. doi: 10.1080/08820139.2016.1197241. Epub 2016 Sep 7. Review.


Cancer-testis antigens: promising targets for antigen directed antineoplastic immunotherapy.

Bodey B.

Expert Opin Biol Ther. 2002 Aug;2(6):577-84. Review.


Expression of synovial sarcoma X (SSX) antigens in epithelial ovarian cancer and identification of SSX-4 epitopes recognized by CD4+ T cells.

Valmori D, Qian F, Ayyoub M, Renner C, Merlo A, Gnjatic S, Stockert E, Driscoll D, Lele S, Old LJ, Odunsi K.

Clin Cancer Res. 2006 Jan 15;12(2):398-404. Erratum in: Clin Cancer Res. 2006 Mar 1;12(5):1656. Gjnatic, Sacha [corrected to Gnjatic, Sacha].


Heterogeneous expression of the SSX cancer/testis antigens in human melanoma lesions and cell lines.

dos Santos NR, Torensma R, de Vries TJ, Schreurs MW, de Bruijn DR, Kater-Baats E, Ruiter DJ, Adema GJ, van Muijen GN, van Kessel AG.

Cancer Res. 2000 Mar 15;60(6):1654-62.


Cancer/testis antigens: an expanding family of targets for cancer immunotherapy.

Scanlan MJ, Gure AO, Jungbluth AA, Old LJ, Chen YT.

Immunol Rev. 2002 Oct;188:22-32. Review.


Functional autoantibodies against SSX-2 and NY-ESO-1 in multiple myeloma patients after allogeneic stem cell transplantation.

Luetkens T, Kobold S, Cao Y, Ristic M, Schilling G, Tams S, Bartels BM, Templin J, Bartels K, Hildebrandt Y, Yousef S, Marx A, Haag F, Bokemeyer C, Kröger N, Atanackovic D.

Cancer Immunol Immunother. 2014 Nov;63(11):1151-62. doi: 10.1007/s00262-014-1588-x. Epub 2014 Jul 31.


SSX cancer testis antigens are expressed in most multiple myeloma patients: co-expression of SSX1, 2, 4, and 5 correlates with adverse prognosis and high frequencies of SSX-positive PCs.

Taylor BJ, Reiman T, Pittman JA, Keats JJ, de Bruijn DR, Mant MJ, Belch AR, Pilarski LM.

J Immunother. 2005 Nov-Dec;28(6):564-75.


Identification of a common HLA-A*0201-restricted epitope among SSX family members by mimicking altered peptide ligands strategy.

He Y, Mao L, Lin Z, Deng Y, Tang Y, Jiang M, Li W, Jia Z, Wang J, Ni B, Wu Y.

Mol Immunol. 2008 May;45(9):2455-64. doi: 10.1016/j.molimm.2008.01.014. Epub 2008 Mar 4.


Assessment of CD4+ T cells specific for the tumor antigen SSX-1 in cancer-free individuals.

Godefroy E, Wang Y, Souleimanian NE, Scotto L, Stevanovic S, Chen YT, Valmori D, Ayyoub M.

Cancer Immunol Immunother. 2007 Aug;56(8):1183-92. Epub 2006 Dec 22.


Infrequent and low expression of cancer-testis antigens located on the X chromosome in colorectal cancer: implications for immunotherapy in South African populations.

Dakshinamurthy AG, Ramesar R, Goldberg P, Blackburn JM.

Biotechnol J. 2008 Nov;3(11):1417-23. doi: 10.1002/biot.200800144.


SSX antigens as tumor vaccine targets in human sarcoma.

Ayyoub M, Brehm M, Metthez G, Talbot S, Dutoit V, Taub RN, Keohan ML, Gure AO, Chen YT, Williamson B, Jungbluth AA, Old LJ, Hesdorffer CS, Valmori D.

Cancer Immun. 2003 Oct 9;3:13.


CD4+ T cell responses to SSX-4 in melanoma patients.

Ayyoub M, Merlo A, Hesdorffer CS, Rimoldi D, Speiser D, Cerottini JC, Chen YT, Old LJ, Stevanovic S, Valmori D.

J Immunol. 2005 Apr 15;174(8):5092-9.


Expression of SSX genes in human tumors.

Türeci O, Chen YT, Sahin U, Güre AO, Zwick C, Villena C, Tsang S, Seitz G, Old LJ, Pfreundschuh M.

Int J Cancer. 1998 Jul 3;77(1):19-23.


[Adaptive immunotherapy of the advanced prostate cancer - cancer testis antigen (CTA) as possible target antigens].

Prikler L, Scandella E, Men Y, Engeler DS, Diener PA, Gillessen S, Ludewig B, Schmid HP.

Aktuelle Urol. 2004 Aug;35(4):326-30. German.


Expression of multiple cancer-testis antigen genes in gastrointestinal and breast carcinomas.

Mashino K, Sadanaga N, Tanaka F, Yamaguchi H, Nagashima H, Inoue H, Sugimachi K, Mori M.

Br J Cancer. 2001 Sep 1;85(5):713-20.


Naturally acquired MAGE-A10- and SSX-2-specific CD8+ T cell responses in patients with hepatocellular carcinoma.

Bricard G, Bouzourene H, Martinet O, Rimoldi D, Halkic N, Gillet M, Chaubert P, Macdonald HR, Romero P, Cerottini JC, Speiser DE.

J Immunol. 2005 Feb 1;174(3):1709-16.


Cancer-testis antigen expression and its epigenetic modulation in acute myeloid leukemia.

Atanackovic D, Luetkens T, Kloth B, Fuchs G, Cao Y, Hildebrandt Y, Meyer S, Bartels K, Reinhard H, Lajmi N, Hegewisch-Becker S, Schilling G, Platzbecker U, Kobbe G, Schroeder T, Bokemeyer C, Kröger N.

Am J Hematol. 2011 Nov;86(11):918-22. doi: 10.1002/ajh.22141. Epub 2011 Sep 2.

Supplemental Content

Support Center